KENNETH K LEW
Broker in Brookline, MA
License number
Massachusetts 44951
Issued Date
Jun 1, 1983
Expiration Date
Dec 22, 1989
Type
Salesperson
Address
Address
Brookline, MA 02172
Professional information
Method For The Commercial Production Of Helminths Antigens
US Patent:
4568639, Feb 4, 1986
Filed:
Feb 21, 1985
Appl. No.:
6/703759
Inventors:
Kenneth K. Lew - Brookline MA
International Classification:
C12P 2100, C12N 1500, A01K 4500, A61K 3900
US Classification:
435 68
Abstract:
An easily cultured worm is genetically modified such that its surface antigens on its modified form are immunologically identical to the surface antigens of a parasitic worm. Specifically, C. elegans is genetically modified to produce antigens corresponding to the antigens of D. immitis which causes heartworm infection. The antigens derived from the easily cultured worm are used to form a vaccine and/or diagnostic.
Method For The Commercial Production Of Helminths Antigens
US Patent:
4756908, Jul 12, 1988
Filed:
Jun 12, 1985
Appl. No.:
6/743877
Inventors:
Kenneth K. Lew - Brookline MA
International Classification:
A61K 3900
US Classification:
424 88
Abstract:
An easily cultured worm is genetically modified such that its surface antigens on its modified form are immunologically identical to the surface antigens of a parasitic worm. Specifically, C. elegans is genetically modified to produce antigens corresponding to the antigens of D. immitis which causes heartworm infection. The antigens derived from the easily cultured worm are used to form a vaccine and/or diagnostic.
Mutagenicity Assay
US Patent:
4345026, Aug 17, 1982
Filed:
Jan 12, 1981
Appl. No.:
6/224100
Inventors:
Kenneth K. Lew - Brookline MA
Assignee:
The Children's Hospital Medical Center - Boston MA
International Classification:
C12Q 100
US Classification:
435 4
Abstract:
Mutagenicity assay method involving exposing a population of an animal species to a suspected mutagen and then scoring the occurrence, in a subsequent generation, of animals of a size substantially different from that of the exposed population as a measure of the mutagenicity of the suspected mutagen.